Thorne HealthTech, Inc. (THRN) reported Q2 EPS of ($0.05), $0.05 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $56.1 million versus the consensus estimate of $56.88 million.
GUIDANCE:
Thorne HealthTech, Inc. sees FY2022 EPS of $0.36-$0.39. Thorne HealthTech, Inc. sees FY2022 revenue of $235-242 million, versus the consensus of $247 million.